Cargando…
Delivery of vascular endothelial growth factor (VEGFC) via engineered exosomes improves lymphedema
BACKGROUND: Lymphedema is a chronic disease results from impaired flow of the lymphatic system. Therefore, reconstruction of lymphatic system is crucial to treat limb lymphedema. Vascular endothelial growth factor (VEGFC) has been reported to be an important regulator involved in the growth and diff...
Autores principales: | Li, Bohan, Yang, Jiantao, Wang, Raoping, Li, Jia, Li, Xubo, Zhou, Xiang, Qiu, Shuai, Weng, Ricong, Wu, Zichao, Tang, Chunyuan, Li, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729376/ https://www.ncbi.nlm.nih.gov/pubmed/33313243 http://dx.doi.org/10.21037/atm-20-6605 |
Ejemplares similares
-
Erratum to delivery of vascular endothelial growth factor (VEGFC) via engineered exosomes improves lymphedema
Publicado: (2021) -
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
por: Szőke, Dániel, et al.
Publicado: (2021) -
Genomic Landscapes of Noncoding RNAs Regulating VEGFA and VEGFC Expression in Endothelial Cells
por: Mushimiyimana, Isidore, et al.
Publicado: (2021) -
Emerging Role of VEGFC in Pathological Angiogenesis
por: Nagai, Nao, et al.
Publicado: (2015) -
The Relationship between VEGFC Gene Polymorphisms and Autoimmune Thyroiditis
por: Gao, Chaoqun, et al.
Publicado: (2022)